These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
558 related articles for article (PubMed ID: 10632357)
1. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Li D; Duan L; Freimuth P; O'Malley BW Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357 [TBL] [Abstract][Full Text] [Related]
2. Novel adenoviral gene delivery system targeted against head and neck cancer. Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343 [TBL] [Abstract][Full Text] [Related]
3. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus. Suominen E; Toivonen R; Grenman R; Savontaus M J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521 [TBL] [Abstract][Full Text] [Related]
4. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer. Rocco JW; Li D; Liggett WH; Duan L; Saunders JK; Sidransky D; O'Malley BW Clin Cancer Res; 1998 Jul; 4(7):1697-704. PubMed ID: 9676844 [TBL] [Abstract][Full Text] [Related]
5. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer. Toivonen R; Suominen E; Grenman R; Savontaus M Oncol Rep; 2009 Jan; 21(1):165-71. PubMed ID: 19082458 [TBL] [Abstract][Full Text] [Related]
6. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy. Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451 [TBL] [Abstract][Full Text] [Related]
7. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function. Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901 [TBL] [Abstract][Full Text] [Related]
8. Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Kawakami Y; Li H; Lam JT; Krasnykh V; Curiel DT; Blackwell JL Cancer Res; 2003 Mar; 63(6):1262-9. PubMed ID: 12649186 [TBL] [Abstract][Full Text] [Related]
9. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines. Pearson AS; Koch PE; Atkinson N; Xiong M; Finberg RW; Roth JA; Fang B Clin Cancer Res; 1999 Dec; 5(12):4208-13. PubMed ID: 10632362 [TBL] [Abstract][Full Text] [Related]
10. Use of protamine to augment adenovirus-mediated cancer gene therapy. Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. O'Malley BW; Chen SH; Schwartz MR; Woo SL Cancer Res; 1995 Mar; 55(5):1080-5. PubMed ID: 7866992 [TBL] [Abstract][Full Text] [Related]
12. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials. Overholt SM; Liu TJ; Taylor DL; Wang M; El-Naggar AK; Shillitoe E; Adler-Storthz K; John LS; Zhang WW; Roth JA; Clayman GL Clin Cancer Res; 1997 Feb; 3(2):185-91. PubMed ID: 9815671 [TBL] [Abstract][Full Text] [Related]
13. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study. Lalonde ES; Beyer G; Friedlander PL; Kolls JK Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941 [TBL] [Abstract][Full Text] [Related]
15. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Yarbrough WG Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329 [TBL] [Abstract][Full Text] [Related]
16. FasL gene therapy: a new therapeutic modality for head and neck cancer. ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and antiangiogenesis by fibroblast growth factor 2-targeted Ad-TK cancer gene therapy. Saito K; Khan K; Sosnowski B; Li D; O'Malley BW Laryngoscope; 2009 Apr; 119(4):665-74. PubMed ID: 19213040 [TBL] [Abstract][Full Text] [Related]
18. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma. Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980 [TBL] [Abstract][Full Text] [Related]
19. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma. Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells. Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]